Based on the activity concentrations and ratios between the PSMA+ and PSMA− tumors, kinetics, and correlation analyses, there was evidence of significantly higher accumulation of the ligand in the PSMA+ tumor. This evidence concerns the gene FOLH1 and neoplasm.